pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-5696 |
Genomic Coordinates | chr2: 101309450 - 101309534 |
Description | Homo sapiens miR-5696 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-5696 | |||||||||
Sequence | 4| CUCAUUUAAGUAGUCUGAUGCC |25 | |||||||||
Evidence | Experimental | |||||||||
Experiments | Illumina | |||||||||
SNPs in miRNA |
|
|||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | IPO7 | ||||||||||||||||||||
Synonyms | Imp7, RANBP7 | ||||||||||||||||||||
Description | importin 7 | ||||||||||||||||||||
Transcript | NM_006391 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on IPO7 | |||||||||||||||||||||
3'UTR of IPO7 (miRNA target sites are highlighted) |
>IPO7|NM_006391|3'UTR 1 GTTATCTCTTTCTTTCCTGCTGTGTGCTTGTAGTGAAGAGCTTGTGTTCCTCCTAGTAGTGGTTCCAGAACTGGTTCATG 81 TTATCTATTCTAAACTAATAATCAATAGATGGACAAAAGAAACAACAACCCCAGGAGATGGGACCTGATCATGCAACCTG 161 GCACTGGAAAAGAAATCAGCGGGATTTTGGGGGTGGGGGGGGATGGGAGGTACCTTAGAGGGAGTATTTTCTTTATTTTT 241 TGAAGAAAGTAAGATCCTGACTCTGAAGCTTCAAAGTGACACTGTGGAAATCTGAAACGAGGGGATGTCATGAAGGCAGC 321 TTTTCTTTTTCTGAGGAAAAAATAGGCATGGGCTACAGGACTATTTAAAATGTCTCATTTACAGTATAAAACTCAAAGGT 401 AGATGTAATTTTTACACCTATGAGTATTTGTCCAATTTCTGTCTCTTCCTCACCATTGGGTATCTATTCTTTATATGTAA 481 ATAAGATAAGGTCATCTGATAGCCTTATTCAGTCTTCATCATTTTCATCATTGTTCCTATGTAGATTATTGGACATTTAT 561 TGTAGCACTACATAACTGATTATAAAAATCTGTAAATGAATTAGCACTTTCATATTGAAACAAGCCTGCTAGCCTATGTA 641 TAAAATAGCAAAATGTTTGCTGTTTATAAAAAGATGTAATGGGGTGGGGGGCAGGGGTAATTTCAAGTTATTAATTTAAA 721 AATGAACTAGCAATTTTGTACCTGGTGACTTTGTGGTGCACTCACCTCTGATAGTGACTTGAATTCGGTATGTAAAAAGG 801 GGTTAGTGGTATTTCATTGCTGCTAAAAATGACAACTCCCTCTGTGTCCTGTTTTTCTTAAAGCTGTCAGTGTACAAGTG 881 GGTATTTGAATACCAGACCTTACTGTAAAAAATAAAAAAGGTGGTATCTAGAGCATGTAAATTGGATATAAAGTTCTGCT 961 CTTAAAGAGTTGATCTAAGAGTATGGCTAAACATCTATATATGCAATCTATTAAAAGAACTTAATTCGGCTATTATGTCT 1041 TGATTTGATTGCAGTTTTTTCCTAATTATAACAAATTTTTCCTCATTGGCCTGTTTTTAATCCTGTGCCTAGAAGGAGTA 1121 CAAAATGCACACTTTACAAAATTGATATTTAACACTTACCCACTCCCCTTTCCCCATCTCTTCTACCGCTCTTGTTGATC 1201 GTGGTATCTGATCTTGACTAGATAGGCTGAAGGCACATGGTTCCCTCCAAAAACCACTATTGATACCACTACAAAAACAA 1281 GCCAGCAAAAAGATACTGTAGAGAGGTTGGCTTGCTTCCCTCTCTTCCTAACTGCATGTTGAAAAATAAGCCGTTATTGA 1361 TCTTAAACATCGGTCAGATGAGTCATACATTGGGTTATTTTTTATATACATGTATACACAAAATATTTCAAATTGAAAGC 1441 AACATCTTAATGGATTCAAAACTATTACAAGCTGTTGTCTAAAACAGGTGAGAAAAAAATTTATAACTGTAAAAACAAAT 1521 GCACATATTGATATTTAAAATGCGTAATTAAGAAAACCCATTGTTGTTGTGTTTTTCTTGTATACCAATAATTAAGCCAC 1601 TACTGTTGGCACTGTTTGGTTTTCTATTTTAACACTGAAGGAGTGAAAGTATTTCCTATATTTATGAATTTACTACTAAA 1681 ATCTTGGCAAAAAAAGAAAAAAATTGTCTAACGTGTGTGGGTGAAAACTGTTAATCAAGTGTTTCTACTCCCCCCCGAAA 1761 ATCCCCTGAAAGTTGGACACCAACTGTATACCCTAGGTTGCTTAAAGGGATTTCACTATTATATAAAGTCAATAAAAATG 1841 AAGTAGTTGTATATATGCAACATTGTGTACAGAGGGGAAATAATGAATAGTATTAAAGAAACATTCTCGTCTTCCTTTAC 1921 CTTTAATCCCCTAATACCTAGTCTACTTTTTAAATTTTCAGACTTCACTGCTTTTTGAATTCATAATTCTAATTTTCACA 2001 TTATTGTTAATGGAAAATCATATCTAATAAAGGTTTTAGTTATTCCCATGCACAGTATGAAAATTCTCATTTGCTGAGGT 2081 TTTGTTTCAAGAAAATGTATTGGCATGTCTTTGAGAACATGTTTTATTGTCTCCTGTGTCATATAATCCAAACTAATCTC 2161 CGTTTACAGACTTTAACTTGAAATTAGACCTTATAATTAAACTATTTAAATAGTGTTCAAATGATAGTTTCTAATGCATC 2241 AAATATATACCTCAGTTTTCATGATTTCCTTTAACATTATAATTTGGTATAGATCAAGAATCTTAACATGTATCAGTTTC 2321 TAGATGAGGCTGCAGGATTTTTGGAAAACTTTTTGAATGTATTTACAATATTCTCTTGTAATTAGCTACATAGGGACTTG 2401 TCTTTTTTTCTTTTTACATACAGCTTTTCCTACAGTTTTATTACCCTGTAATTTTTTTTTAGTTGTAGAAGTTAATTCTG 2481 ATTTTGTGTGGATTTCAGTATTTGTCTTTGTTAATGGCACATATTAGCATAAATCACTTTTGTAAATGTAAGCTTTCTTT 2561 TTTTTTCTTGAAAAAGCCTTTCTATTTATCAGTATTAAATAAAGGAAGTTAATCTGTTTCTCTGCAGGTAATAAAATAGT 2641 GACACACTGTATTAAGATAGTGACTGCTATACTCAACTCTGGAAGAGACTAGAGTATAGAGCATGAGTGGCAAAACCACA 2721 GCCCTTGGGCCATATGCTGCTATTCAGTCCCAGATGTAGCCCCTGAAGCAAGCATAAAGAAAAATGAATTAAAAATTAAA 2801 TTAATATGGAAAGTTAAAAAATGGATTACATTAGTATGACTAAACCATGTCTTTGGCAAAGATCTAACACAATGTCTTAA 2881 GTATAATAGGTAGTCTCTGTTTGTAAAATAAATGACTTAAATTTAAAACATCAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | LCL35 |
Disease | MIMAT0022489 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1020022. RNA binding protein: AGO2. Condition:EBV B95-8-infected
... - Skalsky RL; Corcoran DL; Gottwein E; Frank et al., 2012, PLoS pathogens. |
Article |
- Skalsky RL; Corcoran DL; Gottwein E; Frank et al. - PLoS pathogens, 2012
Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus linked to a number of B cell cancers and lymphoproliferative disorders. During latent infection, EBV expresses 25 viral pre-microRNAs (miRNAs) and induces the expression of specific host miRNAs, such as miR-155 and miR-21, which potentially play a role in viral oncogenesis. To date, only a limited number of EBV miRNA targets have been identified; thus, the role of EBV miRNAs in viral pathogenesis and/or lymphomagenesis is not well defined. Here, we used photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) combined with deep sequencing and computational analysis to comprehensively examine the viral and cellular miRNA targetome in EBV strain B95-8-infected lymphoblastoid cell lines (LCLs). We identified 7,827 miRNA-interaction sites in 3,492 cellular 3'UTRs. 531 of these sites contained seed matches to viral miRNAs. 24 PAR-CLIP-identified miRNA:3'UTR interactions were confirmed by reporter assays. Our results reveal that EBV miRNAs predominantly target cellular transcripts during latent infection, thereby manipulating the host environment. Furthermore, targets of EBV miRNAs are involved in multiple cellular processes that are directly relevant to viral infection, including innate immunity, cell survival, and cell proliferation. Finally, we present evidence that myc-regulated host miRNAs from the miR-17/92 cluster can regulate latent viral gene expression. This comprehensive survey of the miRNA targetome in EBV-infected B cells represents a key step towards defining the functions of EBV-encoded miRNAs, and potentially, identifying novel therapeutic targets for EBV-associated malignancies.
LinkOut: [PMID: 22291592]
|
CLIP-seq Support 1 for dataset GSM1020022 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | LCL35 / EBV B95-8-infected, 4-thiouridine, RNase T1 |
Location of target site | ENST00000379719.3 | 3UTR | UCAAGUUAUUAAUUUAAAAAUGAACUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22291592 / GSE41437 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
145 hsa-miR-5696 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT057820 | SLC30A7 | solute carrier family 30 member 7 | 2 | 2 | ||||||||
MIRT061215 | MED17 | mediator complex subunit 17 | 2 | 2 | ||||||||
MIRT061275 | IPO7 | importin 7 | 2 | 2 | ||||||||
MIRT087540 | YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta | 2 | 2 | ||||||||
MIRT090979 | DPH3 | diphthamide biosynthesis 3 | 2 | 2 | ||||||||
MIRT100413 | HSPA1B | heat shock protein family A (Hsp70) member 1B | 2 | 2 | ||||||||
MIRT108737 | XIAP | X-linked inhibitor of apoptosis | 2 | 2 | ||||||||
MIRT116191 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 4 | ||||||||
MIRT185488 | LBR | lamin B receptor | 2 | 2 | ||||||||
MIRT239133 | GLO1 | glyoxalase I | 2 | 2 | ||||||||
MIRT314678 | TMEM167A | transmembrane protein 167A | 2 | 4 | ||||||||
MIRT365830 | ZBTB33 | zinc finger and BTB domain containing 33 | 2 | 2 | ||||||||
MIRT375653 | VPS53 | VPS53, GARP complex subunit | 2 | 2 | ||||||||
MIRT441652 | DEK | DEK proto-oncogene | 2 | 2 | ||||||||
MIRT442230 | BTD | biotinidase | 2 | 2 | ||||||||
MIRT443351 | ZBTB37 | zinc finger and BTB domain containing 37 | 2 | 2 | ||||||||
MIRT444349 | KIAA1211 | KIAA1211 | 2 | 2 | ||||||||
MIRT444907 | KIAA1841 | KIAA1841 | 2 | 2 | ||||||||
MIRT445301 | PRR26 | proline rich 26 | 2 | 2 | ||||||||
MIRT446678 | SMIM10 | small integral membrane protein 10 | 2 | 2 | ||||||||
MIRT449658 | PRKAA2 | protein kinase AMP-activated catalytic subunit alpha 2 | 2 | 4 | ||||||||
MIRT456346 | OLIG3 | oligodendrocyte transcription factor 3 | 2 | 8 | ||||||||
MIRT466384 | TGOLN2 | trans-golgi network protein 2 | 2 | 4 | ||||||||
MIRT467279 | SPNS1 | sphingolipid transporter 1 (putative) | 2 | 2 | ||||||||
MIRT478065 | DNAJB4 | DnaJ heat shock protein family (Hsp40) member B4 | 2 | 2 | ||||||||
MIRT479422 | CDKN1B | cyclin dependent kinase inhibitor 1B | 2 | 2 | ||||||||
MIRT482866 | SMIM12 | small integral membrane protein 12 | 2 | 4 | ||||||||
MIRT484696 | RNF11 | ring finger protein 11 | 2 | 2 | ||||||||
MIRT497699 | ARL6IP6 | ADP ribosylation factor like GTPase 6 interacting protein 6 | 2 | 2 | ||||||||
MIRT499111 | SNRPB2 | small nuclear ribonucleoprotein polypeptide B2 | 2 | 8 | ||||||||
MIRT500787 | TLK1 | tousled like kinase 1 | 2 | 6 | ||||||||
MIRT504644 | RPL9 | ribosomal protein L9 | 2 | 6 | ||||||||
MIRT505947 | RAN | RAN, member RAS oncogene family | 2 | 6 | ||||||||
MIRT513837 | KCTD15 | potassium channel tetramerization domain containing 15 | 2 | 4 | ||||||||
MIRT514437 | C15orf59 | chromosome 15 open reading frame 59 | 2 | 2 | ||||||||
MIRT518810 | AKAP8 | A-kinase anchoring protein 8 | 2 | 4 | ||||||||
MIRT519802 | ZMYM2 | zinc finger MYM-type containing 2 | 2 | 4 | ||||||||
MIRT525377 | SYNM | synemin | 2 | 2 | ||||||||
MIRT525993 | MAGEL2 | MAGE family member L2 | 2 | 2 | ||||||||
MIRT527715 | SSC5D | scavenger receptor cysteine rich family member with 5 domains | 2 | 4 | ||||||||
MIRT528057 | OLAH | oleoyl-ACP hydrolase | 2 | 2 | ||||||||
MIRT528636 | SENP6 | SUMO1/sentrin specific peptidase 6 | 2 | 2 | ||||||||
MIRT529170 | CCDC25 | coiled-coil domain containing 25 | 2 | 2 | ||||||||
MIRT529585 | TMEM220 | transmembrane protein 220 | 2 | 2 | ||||||||
MIRT529806 | TMLHE | trimethyllysine hydroxylase, epsilon | 2 | 2 | ||||||||
MIRT531260 | PPIL3 | peptidylprolyl isomerase like 3 | 2 | 2 | ||||||||
MIRT531428 | MPZL3 | myelin protein zero like 3 | 2 | 2 | ||||||||
MIRT532139 | ZNF331 | zinc finger protein 331 | 2 | 2 | ||||||||
MIRT532350 | PLEK | pleckstrin | 2 | 2 | ||||||||
MIRT533533 | TPR | translocated promoter region, nuclear basket protein | 2 | 2 | ||||||||
MIRT535822 | MTFR1L | mitochondrial fission regulator 1 like | 2 | 2 | ||||||||
MIRT539243 | ANKRD50 | ankyrin repeat domain 50 | 2 | 2 | ||||||||
MIRT543556 | RPF2 | ribosome production factor 2 homolog | 2 | 4 | ||||||||
MIRT544899 | DCTPP1 | dCTP pyrophosphatase 1 | 2 | 2 | ||||||||
MIRT545103 | RAG1 | recombination activating 1 | 2 | 2 | ||||||||
MIRT549060 | CALM1 | calmodulin 1 | 2 | 2 | ||||||||
MIRT550044 | RSRC1 | arginine and serine rich coiled-coil 1 | 2 | 2 | ||||||||
MIRT550055 | MDM2 | MDM2 proto-oncogene | 2 | 2 | ||||||||
MIRT550475 | TMEM241 | transmembrane protein 241 | 2 | 2 | ||||||||
MIRT550654 | ZFP37 | ZFP37 zinc finger protein | 2 | 2 | ||||||||
MIRT553599 | TM7SF3 | transmembrane 7 superfamily member 3 | 2 | 2 | ||||||||
MIRT554614 | RPS6KA3 | ribosomal protein S6 kinase A3 | 2 | 2 | ||||||||
MIRT555639 | PHIP | pleckstrin homology domain interacting protein | 2 | 2 | ||||||||
MIRT556262 | MAPK6 | mitogen-activated protein kinase 6 | 2 | 2 | ||||||||
MIRT558529 | CSRNP3 | cysteine and serine rich nuclear protein 3 | 2 | 2 | ||||||||
MIRT559171 | BRAP | BRCA1 associated protein | 2 | 2 | ||||||||
MIRT565206 | TROVE2 | TROVE domain family member 2 | 2 | 2 | ||||||||
MIRT566063 | RCC2 | regulator of chromosome condensation 2 | 2 | 2 | ||||||||
MIRT566721 | MSL2 | MSL complex subunit 2 | 2 | 2 | ||||||||
MIRT566775 | KIAA1804 | mitogen-activated protein kinase kinase kinase 21 | 2 | 2 | ||||||||
MIRT567594 | FANCF | Fanconi anemia complementation group F | 2 | 2 | ||||||||
MIRT568752 | DDAH1 | dimethylarginine dimethylaminohydrolase 1 | 2 | 2 | ||||||||
MIRT571253 | ALG10B | ALG10B, alpha-1,2-glucosyltransferase | 2 | 2 | ||||||||
MIRT573768 | PRKAG1 | protein kinase AMP-activated non-catalytic subunit gamma 1 | 2 | 2 | ||||||||
MIRT609525 | AZI2 | 5-azacytidine induced 2 | 2 | 4 | ||||||||
MIRT613118 | EID1 | EP300 interacting inhibitor of differentiation 1 | 2 | 2 | ||||||||
MIRT613588 | MDGA2 | MAM domain containing glycosylphosphatidylinositol anchor 2 | 2 | 2 | ||||||||
MIRT616958 | MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | 2 | 2 | ||||||||
MIRT622619 | PPP2R1B | protein phosphatase 2 scaffold subunit Abeta | 2 | 2 | ||||||||
MIRT624015 | EPHB1 | EPH receptor B1 | 2 | 2 | ||||||||
MIRT624709 | APPL1 | adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1 | 2 | 2 | ||||||||
MIRT625797 | MDC1 | mediator of DNA damage checkpoint 1 | 2 | 2 | ||||||||
MIRT627957 | NLK | nemo like kinase | 2 | 2 | ||||||||
MIRT634868 | CHD4 | chromodomain helicase DNA binding protein 4 | 2 | 2 | ||||||||
MIRT635722 | ALKBH4 | alkB homolog 4, lysine demethylase | 2 | 2 | ||||||||
MIRT636107 | ZBTB7A | zinc finger and BTB domain containing 7A | 2 | 2 | ||||||||
MIRT636943 | LIMS3 | LIM zinc finger domain containing 3 | 2 | 2 | ||||||||
MIRT637009 | LIMS3L | LIM zinc finger domain containing 4 | 2 | 2 | ||||||||
MIRT638057 | YAE1D1 | Yae1 domain containing 1 | 2 | 4 | ||||||||
MIRT640158 | CDK13 | cyclin dependent kinase 13 | 2 | 2 | ||||||||
MIRT640170 | ARFGEF2 | ADP ribosylation factor guanine nucleotide exchange factor 2 | 2 | 2 | ||||||||
MIRT640992 | PROK2 | prokineticin 2 | 2 | 2 | ||||||||
MIRT641339 | RAB11FIP1 | RAB11 family interacting protein 1 | 2 | 2 | ||||||||
MIRT642042 | MAP3K2 | mitogen-activated protein kinase kinase kinase 2 | 2 | 2 | ||||||||
MIRT642074 | FUT11 | fucosyltransferase 11 | 2 | 2 | ||||||||
MIRT642101 | FAM84B | family with sequence similarity 84 member B | 2 | 2 | ||||||||
MIRT642348 | C19orf40 | Fanconi anemia core complex associated protein 24 | 1 | 1 | ||||||||
MIRT642583 | KIAA0101 | PCNA clamp associated factor | 2 | 2 | ||||||||
MIRT644131 | TRAPPC13 | trafficking protein particle complex 13 | 2 | 2 | ||||||||
MIRT646409 | HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 | 2 | 2 | ||||||||
MIRT646829 | TLDC1 | TBC/LysM-associated domain containing 1 | 2 | 2 | ||||||||
MIRT648356 | AKIP1 | A-kinase interacting protein 1 | 2 | 2 | ||||||||
MIRT650019 | ADAMTS8 | ADAM metallopeptidase with thrombospondin type 1 motif 8 | 2 | 2 | ||||||||
MIRT650602 | HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | 2 | 2 | ||||||||
MIRT650727 | TNFSF8 | TNF superfamily member 8 | 2 | 2 | ||||||||
MIRT651322 | ZCCHC2 | zinc finger CCHC-type containing 2 | 2 | 2 | ||||||||
MIRT652450 | TMEM236 | transmembrane protein 236 | 2 | 2 | ||||||||
MIRT652676 | TIGD2 | tigger transposable element derived 2 | 2 | 2 | ||||||||
MIRT652720 | TGFBRAP1 | transforming growth factor beta receptor associated protein 1 | 2 | 2 | ||||||||
MIRT653517 | SLC41A1 | solute carrier family 41 member 1 | 2 | 2 | ||||||||
MIRT654405 | RBBP4 | RB binding protein 4, chromatin remodeling factor | 2 | 2 | ||||||||
MIRT654655 | PSPH | phosphoserine phosphatase | 2 | 2 | ||||||||
MIRT654943 | PNRC1 | proline rich nuclear receptor coactivator 1 | 2 | 2 | ||||||||
MIRT655062 | PKIA | cAMP-dependent protein kinase inhibitor alpha | 2 | 2 | ||||||||
MIRT656554 | LZIC | leucine zipper and CTNNBIP1 domain containing | 2 | 2 | ||||||||
MIRT657666 | GPR26 | G protein-coupled receptor 26 | 2 | 2 | ||||||||
MIRT659634 | CDKN2AIP | CDKN2A interacting protein | 2 | 2 | ||||||||
MIRT660584 | APP | amyloid beta precursor protein | 2 | 2 | ||||||||
MIRT664200 | TBCA | tubulin folding cofactor A | 2 | 2 | ||||||||
MIRT664577 | CD44 | CD44 molecule (Indian blood group) | 2 | 2 | ||||||||
MIRT665240 | ZNF514 | zinc finger protein 514 | 2 | 2 | ||||||||
MIRT665248 | ZNF362 | zinc finger protein 362 | 2 | 2 | ||||||||
MIRT666382 | SHMT1 | serine hydroxymethyltransferase 1 | 2 | 2 | ||||||||
MIRT667264 | NAV2 | neuron navigator 2 | 2 | 2 | ||||||||
MIRT668770 | DCP2 | decapping mRNA 2 | 2 | 2 | ||||||||
MIRT668905 | CREB1 | cAMP responsive element binding protein 1 | 2 | 2 | ||||||||
MIRT669411 | ATP9A | ATPase phospholipid transporting 9A (putative) | 2 | 2 | ||||||||
MIRT672667 | GTF2H5 | general transcription factor IIH subunit 5 | 2 | 2 | ||||||||
MIRT675818 | MAPK14 | mitogen-activated protein kinase 14 | 2 | 2 | ||||||||
MIRT690310 | MRPS30 | mitochondrial ribosomal protein S30 | 2 | 2 | ||||||||
MIRT707804 | TSPAN6 | tetraspanin 6 | 2 | 2 | ||||||||
MIRT709402 | TADA2A | transcriptional adaptor 2A | 2 | 2 | ||||||||
MIRT709982 | RBM41 | RNA binding motif protein 41 | 2 | 2 | ||||||||
MIRT711203 | SMIM14 | small integral membrane protein 14 | 2 | 2 | ||||||||
MIRT714928 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT717438 | TENM1 | teneurin transmembrane protein 1 | 2 | 2 | ||||||||
MIRT717501 | UFL1 | UFM1 specific ligase 1 | 2 | 2 | ||||||||
MIRT719812 | TXNDC17 | thioredoxin domain containing 17 | 2 | 2 | ||||||||
MIRT720569 | TMEM72 | transmembrane protein 72 | 2 | 2 | ||||||||
MIRT721192 | FAIM3 | Fc fragment of IgM receptor | 1 | 1 | ||||||||
MIRT721414 | SEC24A | SEC24 homolog A, COPII coat complex component | 2 | 2 | ||||||||
MIRT721575 | SLC5A12 | solute carrier family 5 member 12 | 2 | 2 | ||||||||
MIRT724675 | NCAPG | non-SMC condensin I complex subunit G | 2 | 2 | ||||||||
MIRT725507 | FUT9 | fucosyltransferase 9 | 2 | 2 | ||||||||
MIRT725533 | EN2 | engrailed homeobox 2 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|